[Frontiers in Bioscience 7, c83-96, August 1, 2002] 83 NOVEL TRENDS IN ORPHAN MARKET DRUG DISCOVERY: AMYOTROPHIC LATERAL SCLEROSIS AS A CASE STUDY

نویسندگان

  • Jennifer E. Clark
  • Avis Brennan
  • Tennore M. Ramesh
  • James Allen Heywood
چکیده

1. Summary 2. Overview 3. Background: General Lead Discovery Trends, 1990-Present 3.1. Overview 3.2. Drug Discovery for Huntington’s Disease 3.3. NIH Anticonvulsant Screening Program. 3.4. Aurora Biosciences and the Cystic Fibrosis Foundation 3.5. Best Practices 4. ALS: Clinical Characteristics and Experimental resources 4.1. Overview 4.2. Trends in ALS Basic Research 4.3. Clinical Development 4.4. Animal Models 4.5. Assays 5. Novel Lead Discovery Programs for ALS 5.1. Overview 5.2. ALS Treatment Initiative 5.3. John Hopkins Center for ALS Research 5.4. ALSA/Hereditary Disease Foundation Collaborative 5.5. ALS Therapy Development Foundation 6. Sources of recent drugs in clinical development 6.1. Overview 6.2. Traditional Lead Discovery 6.3. Theoretical Secondary Indications 6.4. Vitamins, Minerals, and Dietary Supplements 6.5. Clinical Observations 7. Conclusion

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Transcriptomics in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis (ALS) is an adult-onset, incurable neurodegenerative disease characterized by the selective death of upper and lowers motor neurons in the spinal cord, brainstem and motor cortex, which ultimately leads to paralysis and death within 2-3 years of onset. ALS is poorly understood, although multiple studies have been proposed to explain the pathophysiological mechanism...

متن کامل

Amyotrophic Lateral Sclerosis in a Patient with Behçet’s ‎Disease

Behçet’s ‎disease is a multisystem vasculitis. Its neurological involvement mostly includes parenchymal and non-parenchymal central nervous system manifestations. Peripheral nervous system presentations are rare. A 32-yr-old male patient who fulfilled the international study group criteria for Behçet’s disease, referred to our center with walking difficulty and repeated falling downs. Neurologi...

متن کامل

Evaluation of the effectiveness of positive psychology-based interventions on post-traumatic growth, self-compassion and quality of life in patients with amyotrophic lateral sclerosis (ALS)

Introduction: Amyotrophic lateral sclerosis (ALS) is a relatively rare disease that can be associated with various mental, physical and psychological burdens. The aim of this study was to evaluate the effectiveness of interventions based on positive psychology on post-traumatic growth, self-compassion and quality of life in patients with amyotrophic lateral sclerosis. Methods: This descriptive-...

متن کامل

Mutant Profilin1 Aggregation in Amyotrophic Lateral Sclerosis: An in Vivo Biochemical Analysis

Introduction: Profilin1 (PFN1) is a ubiquitously expressed protein known for its function as a regulator of actin polymerization and dynamics. A recent discovery linked mutant PFN1 to Amyotrophic Lateral Sclerosis (ALS), which is a fatal and progressive motor neuron disease. We have also demonstrated that Gly118Val mutation in PFN1 is a cause of ALS, and the formation of aggregates containing m...

متن کامل

Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis is a heterogeneous neurodegenerative syndrome that has been described in the medical literature for 150 years. Numerous theories of cause and pathogenesis have been advanced but specific mechanisms have not yet been established. What is highly likely is that numerous injurious agents can precipitate the cascade of events that results in this well-known syndrome. In...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2002